Toll Free: 1-888-928-9744
Published: Oct, 2016 | Pages:
111 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. The mechanism of action of repaglinide involves promoting insulin release from ?-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia. It is sold by Novo Nordisk under the name of Prandin in the U.S., GlucoNorm in Canada, Surepost in Japan, Repaglinide in Egypt by EIPICO, and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma. This report provides detailed analysis of worldwide markets for Repaglinide from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Repaglinide market and further lays out an analysis of the factors influencing the supply/demand for Repaglinide, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. GCC's report, Global Repaglinide Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Repaglinide market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Repaglinide market are Novo Nordisk (Denmark), API Polpharma (Poland), Aurobindo Pharma (India), Dr.Reddy`s Laboratories (India), Sumitomo Pharmaceuticals (Japan), Hansoh Pharma (China), Hengrui Pharmaceutical (China), Beilu (China), Beijing Winsunny (China), among others. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Repaglinide industry has been provided.
Table of Contents
Part 1. Scope of Report 1.1 Methodology 1.2 Geographic Scope 1.3 Years Considered Part 2. Introduction 2.1 Definition 2.2 Current Scenario 2.2 Future Scenario Part.3 Value Chain Analysis 3.1 Upstream 3.2 Downstream Part 4. Manufacture 4.1 Manufacturing Process 4.2 Issues and Trends 4.3 Manufacturing Costs Part 5. Worldwide Key Vendors 5.1 Company A 5.1.1 Business Overview 5.1.2 Products Offered 5.1.3 Business Performance 5.2 Company B 5.3 Company C 5.4 Company D 5.5 Company E 5.6 Company F 5.7 Company G 5.8 Company H 5.9 Company I 5.10 Company J Part 6. Market Overview 6.1 Global Production Volume 2011-2016 6.2 Production Volume by Region 2011-2016 6.2.1 North America 6.2.2 EMEA 6.2.3 Asia-Pacific 6.2.4 ROW 6.3 Global Production Value 2011-2016 6.4 Production Value by Region 6.4.1 North America 6.4.2 EMEA 6.4.3 Asia-Pacific 6.4.4 ROW Part 7. Consumption Pattern 7.1 Regional Consumption 7.1.1 North America 7.1.2 EMEA 7.1.3 Asia-Pacific 7.1.4 ROW 7.2 Global Consumption by Application Part 8. Market Forecast 8.1 Market Size by Volume 8.1.1 North America 8.1.2 EMEA 8.1.3 Asia-Pacific 8.1.4 ROW 8.2 Market Size by Value 8.2.1 North America 8.2.2 EMEA 8.2.3 Asia-Pacific 8.2.4 ROW 8.3 Regional Consumption Forecast 8.3.1 North America 8.3.2 EMEA 8.3.3 Asia-Pacific 8.3.4 ROW 8.4 Consumption Forecast by Application Part 9. Market Dynamics 9.1 Market Drivers 9.2 Market Constraints 9.3 Market Strategies Part 10. Key Events 10.1 Mergers & Acquisitions 10.2 New Product Launches 10.3 Expansions 10.4 Other Developments List of Tables and Figures
Figure Global Repaglinide Production Volume (Unit) 2011-2016 Figure Global Repaglinide Production Value (M USD) 2011-2016 Figure Top 10 Repaglinide Vendors Production Volume Share 2015 Figure Top 10 Repaglinide Vendors Production Value Share 2015 Figure Regional Repaglinide Production (Unit) 2015 Figure Regional Repaglinide Production Value (M USD) 2015 Table Raw Material Materials Suppliers Figure Global Repaglinide Consumption Pattern 2015 Figure Manufacturing Cost Structure Figure Company A Repaglinide Products Table Company A Financial Performance 2011-2016 Figure Company A Market Share 2011-2016 Figure Company B Repaglinide Products Table Company B Financial Performance 2011-2016 Figure Company B Market Share 2011-2016 Figure Company C Repaglinide Products Table Company C Financial Performance 2011-2016 Figure Company C Market Share 2011-2016 Figure Company D Repaglinide Products Table Company D Financial Performance 2011-2016 Figure Company D Market Share 2011-2016 Figure Company E Repaglinide Products Table Company E Financial Performance 2011-2016 Figure Company E Market Share 2011-2016 Figure Company F Repaglinide Products Table Company F Financial Performance 2011-2016 Figure Company F Market Share 2011-2016 Figure Company G Repaglinide Products Table Company G Financial Performance 2011-2016 Figure Company G Market Share 2011-2016 Figure Company H Repaglinide Products Table Company H Financial Performance 2011-2016 Figure Company H Market Share 2011-2016 Figure Company I Repaglinide Products Table Company I Financial Performance 2011-2016 Figure Company I Market Share 2011-2016 Figure Company J Repaglinide Products Table Company J Financial Performance 2011-2016 Figure Company J Market Share 2011-2016 Table Global Key Repaglinide Vendors Production (Unit) 2011-2016 Table Global Key Repaglinide Vendors Production Share 2011-2016 Figure Global Repaglinide Capacity & Production (Unit), Capacity Utilization 2011-2016 Figure Global Top 10 Repaglinide Vendors Production (Unit) 2011-2016 Table Global Top 10 Repaglinide Vendors Production (Unit) 2011 Table Global Top 10 Repaglinide Vendors Production (Unit) 2012 Table Global Top 10 Repaglinide Vendors Production (Unit) 2013 Table Global Top 10 Repaglinide Vendors Production (Unit) 2014 Table Global Top 10 Repaglinide Vendors Production (Unit) 2015 Table Global Top 10 Repaglinide Vendors Production (Unit) 2016 Figure Repaglinide Production Volume (Unit) 2011-2016 Table Global Production Volume (Unit) 2011-2016 Table Global Production Volume Share 2011-2016 Figure North America Repaglinide Capacity & Production (Unit) Figure North America Production Share Trend Figure EMEA Repaglinide Capacity & Production (Unit) Figure EMEA Production Share Trend Figure Asia-Pacific Repaglinide Capacity & Production (Unit) Figure Asia-Pacific Production Share Trend Figure ROW Repaglinide Capacity & Production (Unit) Figure ROW Production Share Trend Change Figure Global Repaglinide Production Value (M USD), Growth Rate Table Global Key Repaglinide Vendors Production Value (M USD) 2011-2016 Table Global Key Repaglinide Vendors Production Value Share 2011-2016 Figure Global Top 10 Repaglinide Vendors Production Value (M USD) 2011-2016 Table Global Top 10 Repaglinide Vendors Production Value (M USD) 2011 Table Global Top 10 Repaglinide Vendors Production Value (M USD) 2012 Table Global Top 10 Repaglinide Vendors Production Value (M USD) 2013 Table Global Top 10 Repaglinide Vendors Production Value (M USD) 2014 Table Global Top 10 Repaglinide Vendors Production Value (M USD) 2015 Table Global Top 10 Repaglinide Vendors Production Value (M USD) 2016 Figure Repaglinide Prices (USD/Ton) 2016 Figure Repaglinide Gross Margin 2016 Figure Repaglinide Production Value (M USD) By Region 2011-2016 Table Global Repaglinide Production Value (M USD) 2011-2016 Table Global Repaglinide Production Value Share 2011-2016 Figure North America Production Value (M USD), Growth Rate Figure North America Repaglinide Production Value Share Trend Figure EMEA Production Value (M USD), Growth Rate Figure EMEA Repaglinide Production Value Share Trend Figure Asia-Pacific Production Value (M USD), Growth Rate Figure Asia-Pacific Repaglinide Production Value Share Trend Figure ROW Production Value (M USD), Growth Rate Figure ROW Repaglinide Production Value Share Trend Figure Global Repaglinide Consumption Volume (Unit) 2015 Table Regional Repaglinide Consumption Volume (Unit) 2011-2016 Table Regional Repaglinide Consumption Volume Share 2011-2016 Figure Repaglinide Consumption in North America 2011-2016 Figure Repaglinide Consumption in EMEA 2011-2016 Figure Repaglinide Consumption in Asia-Pacific 2011-2016 Figure Repaglinide Consumption in ROW 2011-2016 Figure Global Repaglinide Consumption Volume (Unit) 2016 Table Global Repaglinide Consumption Volume (Unit) 2011-2016 Table Global Repaglinide Consumption Volume Share 2011-2016 Figure Global Repaglinide Production (Unit) Forecast 2016-2021 Table Global Repaglinide Production (Unit) 2016-2021 Table Global Repaglinide Production Share 2016-2021 Figure North Repaglinide Production (Unit) Forecast 2016-2021 Figure EMEA Repaglinide Production (Unit) Forecast 2016-2021 Figure Asia-Pacific Repaglinide Production (Unit) Forecast 2016-2021 Figure ROW Repaglinide Production (Unit) Forecast 2016-2021 Figure Global Repaglinide Revenue (M USD) Forecast 2016-2021 Table Global Repaglinide Revenue (M USD) 2016-2021 Table Global Repaglinide Revenue Share 2016-2021 Figure North America Repaglinide Revenue (M USD) Forecast 2016-2021 Figure EMEA Repaglinide Revenue (M USD) Forecast 2016-2021 Figure Asia-Pacific Repaglinide Revenue (M USD) Forecast 2016-2021 Figure ROW Repaglinide Revenue (M USD) Forecast 2016-2021 Figure Global Repaglinide Consumption Volume (Unit) 2016-2021 Table Global Repaglinide Consumption Volume (Unit) 2016-2021 Table Global Repaglinide Consumption Volume Share 2016-2021 Figure North America Repaglinide Consumption (Unit) Forecast Figure EMEA Repaglinide Consumption (Unit) Forecast Figure Asia-Pacific Repaglinide Consumption (Unit) Forecast Figure ROW Repaglinide Consumption (Unit) Forecast Figure Global Repaglinide Consumption Volume (Unit) 2021 Table Global Repaglinide Consumption Volume (Unit) 2016-2021 Table Global Repaglinide Consumption Volume Share 2016-2021 Table Key Strategies for Repaglinide Multinational Corporations Table Key Strategies for Repaglinide Emerging-Market Players
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.